Novel serotonin receptor 2 (5-HT2R) agonists and antagonists: a patent review (2004-2014).

about

Novel serotonin receptor 2 (5-HT2R) agonists and antagonists: a patent review (2004-2014).

Item

http://www.wikidata.org/entity/Q38648544

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Novel serotonin receptor 2 (5- ...... : a patent review (2004-2014).

@en

type

Item

label

Novel serotonin receptor 2 (5- ...... : a patent review (2004-2014).

@en

prefLabel

Novel serotonin receptor 2 (5- ...... : a patent review (2004-2014).

@en

P1476

Novel serotonin receptor 2 (5- ...... : a patent review (2004-2014).

@en

P2093

Ji-Fu Wei

http://www.w3.org/2001/XMLSchema#string

Linghuan Gao

http://www.w3.org/2001/XMLSchema#string

Shu An

http://www.w3.org/2001/XMLSchema#string

Tian-Rui Xu

http://www.w3.org/2001/XMLSchema#string

Xiao-Xi Guo

http://www.w3.org/2001/XMLSchema#string

Yang Yang

http://www.w3.org/2001/XMLSchema#string

Ying Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Psychedelics and the human receptorome

Serotonin and angiotensin receptors in cardiac fibroblasts coregulate adrenergic-dependent cardiac hypertrophy

The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo

In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties

Structural Features for Functional Selectivity at Serotonin Receptors

Serotonin, via 5-HT2A receptors, increases EPSCs in layer V pyramidal cells of prefrontal cortex by an asynchronous mode of glutamate release

A review of central 5-HT receptors and their function

Parallel functional activity profiling reveals valvulopathogens are potent 5-hydroxytryptamine(2B) receptor agonists: implications for drug safety assessment

Serotonin 5-HT2B receptor in cardiac fibroblast contributes to cardiac hypertrophy: a new therapeutic target for heart failure?

Biarylcarbamoylindolines are novel and selective 5-HT(2C) receptor inverse agonists: identification of 5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]- 5-pyridyl]carbamoyl]-6-trifluoromethylindoline (SB-243213) as a potential antidepressant/anxiolytic agent

P304

89-106

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/13543776.2016.1113257

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

284728335

http://www.w3.org/2001/XMLSchema#string

P698

26609882

http://www.w3.org/2001/XMLSchema#string

P921

serotonin